(Q48337320)

10 February 2018

title

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States (English)

1 reference

10 February 2018

1 reference

1 reference

coronary artery disease

1 reference

3

1 reference

10 February 2018

Noel S. Weiss

2

object named as

Noel S Weiss

1 reference

10 February 2018

Dariush Mozaffarian

4

object named as

Dariush Mozaffarian

1 reference

10 February 2018

author name string

George N Ioannou

1

1 reference

10 February 2018

Sum P Lee

5

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

10 February 2018

published in

Hepatology

1 reference

10 February 2018

volume

43

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

1145-1151

1 reference

10 February 2018

Prediction of Coronary Heart Disease Using Risk Factor Categories

cites work

1 reference

Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies.

21 January 2018

1 reference

Multivariate prediction of coronary heart disease in the Western Collaborative Group Study compared to the findings of the Framingham study

21 January 2018

1 reference

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

7 January 2021

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

7 January 2021

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

7 January 2021

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

7 January 2021

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

7 January 2021

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

1 reference

7 January 2021

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

7 January 2021

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

7 January 2021

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

1 reference

7 January 2021

Defining nonalcoholic fatty liver disease: implications for epidemiologic studies

1 reference

7 January 2021

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

1 reference

7 January 2021

Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology

1 reference

7 January 2021

Liver fibrosis in overweight patients

1 reference

7 January 2021

Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease

1 reference

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

7 January 2021

The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002.

1 reference

7 January 2021

Circulatory dysfunction in NAFLD--which is first, which is last, and what do we do in between?

1 reference

7 January 2021

Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study

1 reference

7 January 2021

Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21171

1 reference

10 February 2018

1 reference

10 February 2018